[Beta-lactam antibiotics: when and how in acute otitis media and pharyngotonsillitis]

G Schito1, P Marchisio, L Bellussi

  • 1Istituto di Microbiologia Clinica, Università degli Studi, Genova.

Insights

Pediatric acute otitis media (AOM) and pharyngitis treatment guidelines lack consensus on diagnosis and antibiotic choice. This review discusses controversies in empiric antibacterial therapy, focusing on beta-lactams.

Area of Science:

  • Pediatric infectious diseases
  • Pharmacology
  • Microbiology

Context:

  • Acute otitis media (AOM) and pharyngitis are common pediatric infections.
  • Current diagnostic criteria and empiric antibacterial treatment guidelines are often debated.
  • Choosing appropriate antibiotics and treatment duration presents challenges for clinicians.

Purpose:

  • To discuss emerging controversies in the empiric treatment of AOM and pharyngitis in children.
  • To highlight special considerations regarding beta-lactam antibiotics.
  • To review recent evidence on clinical pharmacology and microbiology relevant to treatment decisions.

Summary:

  • There is significant disagreement regarding diagnostic criteria and empiric antibiotic selection for pediatric AOM and pharyngitis.
  • Navigating diverse treatment guidelines and antibiotic options is complex.
  • Recent evidence on pharmacology and microbiology is crucial for understanding controversies, particularly concerning beta-lactams.

Impact:

  • Aims to clarify current debates in pediatric infectious disease treatment.
  • Provides insights for optimizing antibiotic selection and duration.
  • Contributes to evidence-based decision-making for common childhood infections.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...